Please select the option that best describes you:

What approach, or dosing interval, do you find is most effective reducing side effects of Hedgehog Inhibitors (i.e., vismodegib) for patients with numerous BCC?   



Answer from: Medical Oncologist at Academic Institution
Sign in or Register to read more

Answer from: at Community Practice
Sign in or Register to read more